Thymus-marrow cell combinations. Synergism in antibody production - PubMed (original) (raw)

Thymus-marrow cell combinations. Synergism in antibody production

H N Claman et al. Proc Soc Exp Biol Med. 1966 Aug-Sep.

No abstract available

PubMed Disclaimer

Similar articles

• Repopulation of thymus, spleen and bone-marrow of irradiated AKR mice injected with normal or irradiated bone-marrow cells.
  Lĕonard A, Decléve A, Maisin JR. Lĕonard A, et al. Experientia. 1971 Oct 15;27(10):1212-4. doi: 10.1007/BF02286936. Experientia. 1971. PMID: 5127887 No abstract available.
• Immunocompetence of transferred thymus-marrow cell combinations.
  Claman HN, Chaperon EA, Triplett RF. Claman HN, et al. J Immunol. 1966 Dec;97(6):828-32. J Immunol. 1966. PMID: 5333748 No abstract available.
• Separate thymus dependent and thymus independent antibody forming cell precursors.
  Playfair JH, Purves EC. Playfair JH, et al. Nat New Biol. 1971 Jun 2;231(22):149-51. doi: 10.1038/newbio231149a0. Nat New Biol. 1971. PMID: 5283017 No abstract available.
• Regneration of thymus, spleen and bone marrow in x-irradiated AKR mice.
  Decleve A, Gerber GB, Leonard A, Lambiet-Collier M, Sassen A, Maisin JR. Decleve A, et al. Radiat Res. 1972 Aug;51(2):318-32. Radiat Res. 1972. PMID: 5050463 No abstract available.
• Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence.
  Claman HN, Chaperon EA. Claman HN, et al. Transplant Rev. 1969;1:92-113. doi: 10.1111/j.1600-065x.1969.tb00137.x. Transplant Rev. 1969. PMID: 4945477 Review. No abstract available.

Cited by

• Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph node.
  Melo-Silva CR, Sigal LJ. Melo-Silva CR, et al. Cell Mol Immunol. 2024 Sep;21(9):999-1007. doi: 10.1038/s41423-024-01188-0. Epub 2024 Jun 25. Cell Mol Immunol. 2024. PMID: 38918577 Free PMC article. Review.
• Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma-A Review.
  Devaraja K, Aggarwal S, Singh M. Devaraja K, et al. Vaccines (Basel). 2023 Mar 13;11(3):634. doi: 10.3390/vaccines11030634. Vaccines (Basel). 2023. PMID: 36992219 Free PMC article. Review.
• CITEMOXMBD: A flexible single-cell multimodal omics analysis framework to reveal the heterogeneity of immune cells.
  Hu H, Liu R, Zhao C, Lu Y, Xiong Y, Chen L, Jin J, Ma Y, Su J, Yu Z, Cheng F, Ye F, Liu L, Zhao Q, Shuai J. Hu H, et al. RNA Biol. 2022 Jan;19(1):290-304. doi: 10.1080/15476286.2022.2027151. RNA Biol. 2022. PMID: 35130112 Free PMC article.
• The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes.
  Tong ZWM, Grant E, Gras S, Wu M, Smith C, Barrett HL, Gallo LA, Short KR. Tong ZWM, et al. FEBS J. 2021 Sep;288(17):5042-5054. doi: 10.1111/febs.16105. Epub 2021 Jul 31. FEBS J. 2021. PMID: 34216102 Free PMC article. Review.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.